BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN AND Prognosis
27 results:

  • 1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The jak3
    Lahera A; Vela-Martín L; Fernández-Navarro P; Llamas P; López-Lorenzo JL; Cornago J; Santos J; Fernández-Piqueras J; Villa-Morales M
    Mol Carcinog; 2024 Jan; 63(1):5-10. PubMed ID: 37712558
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia.
    Brothers J; Castillo DR; Jeon WJ; Joung B; Linhares Y
    Hematology; 2023 Dec; 28(1):2237342. PubMed ID: 37485976
    [No Abstract]    [Full Text] [Related]  

  • 4. Characteristics of Molecular Genetic Mutations and Their Correlation with prognosis in Adolescent and Adult Patients with Acute Lymphoblastic leukemia.
    Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
    Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
    Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
    Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.
    Maciel ALT; Wolch K; Emerenciano M; Mansur MB
    Genes Chromosomes Cancer; 2022 Jul; 61(7):437-442. PubMed ID: 35253299
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The association of complex genetic background with the prognosis of acute leukemia with ambiguous lineage.
    Huang J; Zhou J; Xiao M; Mao X; Zhu L; Liu S; Li Q; Wang J; Zhou J; Cai H; Wang G
    Sci Rep; 2021 Dec; 11(1):24290. PubMed ID: 34934076
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Gene Mutation in Acute Lymphoblastic leukemia by DNA Sequencing].
    Zheng RY; Wang SJ; Wang C; Li T; Liao LX; Li ML; Chen SM; Guo R; Wang WQ; Zhang Y; Fan Y; Wan DM; Liu YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1791-1795. PubMed ID: 33283700
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Failure of tofacitinib to achieve an objective response in a
    Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
    Kim R; Boissel N; Touzart A; Leguay T; Thonier F; Thomas X; Raffoux E; Huguet F; Villarese P; Fourrage C; Passini L; Hunault M; Lepretre S; Chevallier P; Braun T; Lhéritier V; Chantepie S; Maury S; Escoffre M; Tavernier E; Chalandon Y; Graux C; Macintyre E; Ifrah N; Asnafi V; Dombret H; Lhermitte L;
    Leukemia; 2020 Jul; 34(7):1730-1740. PubMed ID: 31992840
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The clinical mutatome of core binding factor leukemia.
    Opatz S; Bamopoulos SA; Metzeler KH; Herold T; Ksienzyk B; Bräundl K; Tschuri S; Vosberg S; Konstandin NP; Wang C; Hartmann L; Graf A; Krebs S; Blum H; Schneider S; Thiede C; Middeke JM; Stölzel F; Röllig C; Schetelig J; Ehninger G; Krämer A; Braess J; Görlich D; Sauerland MC; Berdel WE; Wörmann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
    Leukemia; 2020 Jun; 34(6):1553-1562. PubMed ID: 31896782
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Companion gene mutations and their clinical significance in AML with double mutant CEBPA.
    Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Teng W; Cao P; Nie D; Ma X; Wang T; Lu P; Liu H
    Cancer Gene Ther; 2020 Aug; 27(7-8):599-606. PubMed ID: 31477806
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
    Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
    J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Large granular lymphocytic leukemia. Current diagnostic and therapeutic approaches and novel treatment options.
    Matutes E
    Expert Rev Hematol; 2017 Mar; 10(3):251-258. PubMed ID: 28128670
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
    Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
    Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Transcriptome Study of Subtype M2 Acute Myeloblastic leukemia.
    Wu AY; Yang HC; Lin CM; Wu BD; Qu QS; Zheng YH; Wei H; Mei XQ; Zeng ZH; Ma XD
    Cell Biochem Biophys; 2015 Jul; 72(3):653-6. PubMed ID: 27352183
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mutations of SETBP1 and jak3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.
    Bresolin S; De Filippi P; Vendemini F; D'Alia M; Zecca M; Meyer LH; Danesino C; Locatelli F; Masetti R; Basso G; Te Kronnie G
    Oncotarget; 2016 May; 7(20):28914-9. PubMed ID: 26980750
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.
    Nairismägi ML; Tan J; Lim JQ; Nagarajan S; Ng CC; Rajasegaran V; Huang D; Lim WK; Laurensia Y; Wijaya GC; Li ZM; Cutcutache I; Pang WL; Thangaraju S; Ha J; Khoo LP; Chin ST; Dey S; Poore G; Tan LH; Koh HK; Sabai K; Rao HL; Chuah KL; Ho YH; Ng SB; Chuang SS; Zhang F; Liu YH; Pongpruttipan T; Ko YH; Cheah PL; Karim N; Chng WJ; Tang T; Tao M; Tay K; Farid M; Quek R; Rozen SG; Tan P; Teh BT; Lim ST; Tan SY; Ong CK
    Leukemia; 2016 Jun; 30(6):1311-9. PubMed ID: 26854024
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic characterization of T-PLL reveals two major biologic subgroups and jak3 mutations as prognostic marker.
    Stengel A; Kern W; Zenger M; Perglerová K; Schnittger S; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2016 Jan; 55(1):82-94. PubMed ID: 26493028
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
    Kiel MJ; Sahasrabuddhe AA; Rolland DCM; Velusamy T; Chung F; Schaller M; Bailey NG; Betz BL; Miranda RN; Porcu P; Byrd JC; Medeiros LJ; Kunkel SL; Bahler DW; Lim MS; Elenitoba-Johnson KSJ
    Nat Commun; 2015 Sep; 6():8470. PubMed ID: 26415585
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.